Search details
1.
The Brazilian national prospective active surveillance (AS) cohort of patients with low-risk prostate cancer in the public health system: vigiaSUS study protocol.
BMC Urol
; 23(1): 208, 2023 Dec 11.
Article
in English
| MEDLINE | ID: mdl-38082337
2.
Clinical and genomic features of SPOP-mutant prostate cancer.
Prostate
; 82(2): 260-268, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34783071
3.
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
BJU Int
; 130(5): 592-603, 2022 11.
Article
in English
| MEDLINE | ID: mdl-34597472
4.
Genomic profiles and clinical outcomes in primary versus secondary metastatic hormone-sensitive prostate cancer.
Prostate
; 81(9): 572-579, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33955569
5.
Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer.
Oncologist
; 26(2): e270-e278, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33215787
6.
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes.
BJU Int
; 128(2): 196-205, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33556233
7.
Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors.
Cancer
; 126(6): 1208-1216, 2020 03 15.
Article
in English
| MEDLINE | ID: mdl-31829450
8.
Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study.
J Urol
; 204(1): 63-70, 2020 07.
Article
in English
| MEDLINE | ID: mdl-31971495
9.
A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancer.
Prostate
; 79(14): 1597-1603, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31361358
10.
Genomic and clinical characterization of pulmonary-only metastatic prostate cancer: A unique molecular subtype.
Prostate
; 79(13): 1572-1579, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31389628
11.
Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer.
Prostate
; 78(5): 401-407, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29368341
12.
Prospective Study of Homologous Recombination Repair Gene Mutation Prevalence in Patients With Advanced Prostate Cancer From Latin America: Challenges and Future Approaches.
JCO Precis Oncol
; 8: e2300628, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38748947
13.
Point: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer: The Case for Chemotherapy.
Oncology (Williston Park)
; 32(5): 223-6, 2018 05 15.
Article
in English
| MEDLINE | ID: mdl-29847851
14.
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 20(5): e440-e452, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35778337
15.
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 20(6): 558-567, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36155169
16.
The development of apalutamide for the treatment of prostate cancer.
Expert Opin Drug Discov
; 16(3): 217-226, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33003959
17.
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited.
Eur Urol
; 80(5): 632-640, 2021 11.
Article
in English
| MEDLINE | ID: mdl-33419682
18.
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.
Eur Urol Oncol
; 4(3): 464-472, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33423945
19.
Targeting the immune system in head and neck cancer.
Curr Opin Oncol
; 27(3): 157-8, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25850579
20.
Prognostic Value of Systemic Inflammatory Biomarkers in Patients with Metastatic Renal Cell Carcinoma.
Pathol Oncol Res
; 26(4): 2489-2497, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32583330